ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1009

Pregnancy Outcomes and Comorbidities Among Individuals with Systemic Lupus Erythematosus: A Nationwide Study Using Publicly Funded Health Insurance Claims Data

Amadeia Rector1, Sadaf Sediqi2, Alyssa Howren2 and Julia F Simard3, 1Stanford University, San Francisco, CA, 2Stanford University, Palo Alto, CA, 3Stanford Medicine, Stanford, CA

Meeting: ACR Convergence 2025

Keywords: Epidemiology, pregnancy, Systemic lupus erythematosus (SLE), Women's health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1007–1037) Epidemiology & Public Health Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Individuals with SLE are at increased risk for pregnancy complications such as preeclampsia and preterm delivery. As SLE is commonly diagnosed and active during the childbearing years—and more individuals are pursuing pregnancy due to improved management—there is a growing need to better understand pregnancy outcomes in this population. To address this, we describe pregnancy characteristics and outcomes among individuals enrolled in Medicaid, a publicly funded health insurance program available nationwide.

Methods: Using data from Medicaid T‑MSIS Analytic Files (TAF), we identified all pregnancies for patients with SLE from 2014 to 2019. SLE was defined as ≥2 ICD coded outpatient visits occurring less than 30 days apart or ≥1 ICD coded inpatient visit (ICD9: 710.0, ICD10: M32.1X, M32.8, M32.9) occurring before or during pregnancy. We described demographic factors (age, race and ethnicity, and income relative to federal poverty level) and pregnancy characteristics (parity, delivery type, complications, comorbidities occurring during and before pregnancy, and pregnancy outcomes). Additionally, we stratified the pregnancy outcomes by race.

Results: This diverse cohort consisted of 9391 pregnancies among 8201 individuals with SLE , with 2% identifying as Asian, 29% as Black, 17% as Hispanic, and 32% as white. Forty-four percent were below the federal poverty level. Most pregnancy were livebirths (93%). Approximately 16% of pregnancies were complicated by preeclampsia and 18% resulted in preterm delivery. (Table 1). When stratified by race, Black individuals had the highest prevalence of preeclampsia (19%) and preterm delivery (22%). (Table 2)

Conclusion: Pregnancies among patients with SLE had a high frequency of preeclampsia and preterm delivery compared to estimates in the general population (3-7% preeclampsia and 10% preterm). Black individuals had the highest prevalence of complications. These findings offer contemporary, national estimates of pregnancy complications and outcomes among publicly-insured individuals with SLE, highlighting variations by parity and comorbidity burden, and provide patients and providers with further data to inform pregnancy planning and risk counseling.

Supporting image 1

Supporting image 2


Disclosures: A. Rector: None; S. Sediqi: None; A. Howren: None; J. Simard: None.

To cite this abstract in AMA style:

Rector A, Sediqi S, Howren A, Simard J. Pregnancy Outcomes and Comorbidities Among Individuals with Systemic Lupus Erythematosus: A Nationwide Study Using Publicly Funded Health Insurance Claims Data [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/pregnancy-outcomes-and-comorbidities-among-individuals-with-systemic-lupus-erythematosus-a-nationwide-study-using-publicly-funded-health-insurance-claims-data/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pregnancy-outcomes-and-comorbidities-among-individuals-with-systemic-lupus-erythematosus-a-nationwide-study-using-publicly-funded-health-insurance-claims-data/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology